Benign or cancerous?

November 12, 2008

Findings from new University of Leicester investigation into benign moles and malignant melanoma to be announced at public lecture on Nov. 12

Research into a cancer that is on the rise in the UK is to be presented at the University of Leicester.

It will discuss new studies at Leicester into the differences between benign and cancerous moles.

Postgraduate researcher Dr Philip Da Forno of the Department of Cancer Studies and Molecular Studies will describe new advances in the fight against malignant melanoma at a Doctoral Inaugural Lecture to be given on 12 November.

Dr Da Forno has investigated the expression of a particular protein in the progress of the disease and the molecular differences between types of 'Spitzoid' melanocytic tumours and malignant melanoma

He said: "Malignant melanoma is a common cancer of the skin that is increasing in incidence in the United Kingdom. Early cancers are easily cured but once the disease has spread to other sites in the body, there is no effective treatment and the outcome is often fatal.

"I will discuss our current understanding of how melanocytic lesions progress from benign tumours or small, easily curable cancers, to advanced, frequently fatal cancers. This will include a description of my investigation into expression of the protein Wnt5a during tumour progression and its effect on patient survival."

The diagnosis of melanoma is achieved via microscopic examination of lesional tissue. In the majority of cases this is straightforward and, having made the diagnosis of malignancy, the histopathologist applies a number of criteria to determine which tumours are likely to have been cured by excision and which are at risk of spreading elsewhere and killing the patient. Unfortunately, the behaviour of the tumour cannot always be predicted with accuracy and some patients with seemingly indolent tumours have rapidly progressive disease.

In some instances histological assessment is complicated further by a difficulty in determining whether the tumour is a benign 'mole' or a malignant melanoma. Nowhere is this more acute than in the setting of Spitzoid tumours where the differential diagnosis lies between a benign mole called a Spitz naevus and malignant melanoma

Dr Da Forno will also describe his investigation into the molecular differences between types of Spitzoid lesions and malignant melanoma. This study aimed to determine whether Spitz naevi share molecular features with common benign moles and malignant melanoma, and whether they are capable of progressing to become malignant melanomas.

The Molecular Pathology of Progression in Melanocytic Tumours takes place on Wednesday 12th November at 5:30 pm in the Frank and Katherine May lecture theatre, University of Leicester. It is open to the public and free.

University of Leicester

---

---

	Malignant Melanoma: Your Way Forward by Abaco Publishing You will never cure anything if you don’t do something about the underlying cause. This applies to every illness including malignant melanoma. In my book ‘Malignant Melanoma – Your way Forward’ I explain why it may have developed, giving you something to do to change the underlying causes and bring things under control. It could be related to a vaccination, being burned in the sun, associated with bad eating habits, a poor immune system, infections, too many antibiotics, toxic chemicals, geopathic stress and certainly stresses of everyday life affecting your emotions. When cancer declares itself, it could have been developing for ten or fifteen years. All of this is explained to you in detail as though you are with me in my consulting room. I then give ideas on how to change your...
	Pathology of Melanocytic Nevi and Malignant Melanoma by Michael Piepkorn (Editor), Klaus J. Busam (Editor), Raymond L. Barnhill (Editor) Highly acclaimed and considered the leading reference in the field, Pathology of Melanocytic Nevi and Malignant Melanoma has now been fully revised and updated to accomodate rapid advances in the field of melanoma pathology. Drs. Michael Piepkorn and Klaus Busam have now joined Dr. Barnhill, world-renowned expert in dermatology and pathology, to expand the text with new sections on the genetics and cytogenetics of melanoma,  sentinal lymph node biopsy, the new AJCC TNM staging system for melanoma, the mechanisms of melanoma metastasis. The successful focus and format of the first edition have been preserved. Each lesion and diagnosis is clearly illustrated, now with more than 340 new, digitally enhanced full-color photomicrographs and over 125 tables. A corresponding precis, or concise...
	Pathology of Malignant Melanoma by Raymond L. Barnhill (Author), M.J. Trotter (Contributor) An excerpt from "Pathology of Melanocytic Nevi and Malignant Melanoma, Second Edition", Pathology of Malignant Melanoma provides a highly practical approach to the histopathological diagnosis of melanoma of the skin. Emphasis is placed on the differential diagnosis of major forms of conventional melanoma, and the book also discusses unusual or rare variants that are difficult to recognize. This portable, user-friendly handbook addresses epidemiology, criteria for diagnosis and classification of melanoma, risk factors, and other morphological and cytological variants. More than 30 easy-to-read tables provide at-a-glance reference and over 100 full color illustrations complement the text.
	Malignant Melanoma: Clinical and Histological Diagnosis (A Wiley medical publication) by Vincent J. McGovern (Author)
	Pocket Guide to Malignant Melanoma by John Buchan (Author), Dafydd Roberts (Author) The ability to diagnose melanomas and ensure that they are properly and swiftly treated can save lives. The latter part of this century has witnessed a rise in the incidence of this life-threatening form of skin cancer, which is linked to sun exposure. Public health campaigns have begun to raise awareness of the problem and people are now seeking medical advice about pigmented lesions. The reader is guided through the diagnosis and differential diagnosis with the aid of full color photographs, and there is a guide to interpreting the pathology report.
	Epidemiological Aspects of Cutaneous Malignant Melanoma (Developments in Oncology) by Richard P. Gallagher (Editor), J. Mark Elwood (Editor) Significant progress has been made in recent years in understanding the origins of cutaneous maligant melanoma. Knowledge of the relationship between solar radiation and melanoma has changed and it now appears that both the character and timing of exposure may be more important than total cumulative dose in accounting for risk. The melanoma-sunlight model may prove an instructive heuristic exercise for environmental epidemiology, as we currently tend to restrict ourselves to a search for uniform total dose--response relationships between cancers and suspected environmental carcinogens. The study of the relationship between acquired melanocytic nevi and melanoma has led to useful new information about predictors of melanoma risk, and in addition has opened new perspectives...
	Pitfalls in Histopathologic Diagnosis of Malignant Melanoma by A. Bernard Ackerman (Author), L. Cerroni (Author), H. Kerl (Author) This volume aims to provide the reader with comprehensive, systematic and effective information about pitfalls in the histopathologic diagnosis of malignant melanoma by highlighting a range of pitfalls in histopathologic diagnosis of malignant melanoma and instructing them in a method that enables pitfalls to be avoided. The method utilizes repeatable criteria for the histopathologic diagnosis of melanocytic neoplasms of all kinds, based on features of their architectural pattern, particularly their silhouettes. Proper use of this method is demonstrated in an introduction that establishes firm repeatable criteria for benign and malignant neoplasms of melanocytes.
	Malignant Melanoma by Irving M. Ariel (Editor)
	Pathology of malignant melanoma (Masson monographs in dermatopathology) by A. Bernard Ackerman (Author)
	Malignant Melanoma and Melanocytic by Leboit (Author)